International Journal of Alzheimer’s Disease

Biomarkers for Dementia


Publishing date
01 Jun 2011
Status
Published
Submission deadline
01 Dec 2010

Lead Editor

1Department of Biological Regulation, Faculty of Medicine, Tottori University, Yonago, Tottori 680-8550, Japan

2Department of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan

3Transitional Medicine, Pfizer Global Research and Development Eastern Pt, Road, Groton, CT 06340, USA

4Laboratorio di Epidemiologia, Neuroimaging e Telemedicina, IRCCS Centro San Giovanni di Dio FBF, Via Pilastroni 1, Brescia, Italy


Biomarkers for Dementia

Description

The development of treatments for dementia is advancing with steady steps, and early diagnosis is considered critical. Biomarkers are central components of drug development in Alzheimer's disease and related disorders including dementia with lewy bodies, frontotemporal dementia, and vascular dementia, and so forth. Therefore, we would like to focus upon biomarkers as the theme.

We invite authors to submit original research and review articles about biomarkers for Alzheimer's disease and related disorders including dementia with lewy bodies, frontotemporal dementia, and vascular dementia in basic and clinical research. Potential topics include, but are not limited to:

  • Recent developments of genetic testing
  • Advances of structural imaging (CT, MRI, etc.)
  • Advances of functional imaging (SPECT, PET, Amyloid imaging, etc.)
  • Recent developments of peripheral markers (cerebrospinal fluid, serum, fibroblast, etc.)
  • Role of new biomarkers for disease modifying therapies

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

International Journal of Alzheimer’s Disease
 Journal metrics
Acceptance rate17%
Submission to final decision100 days
Acceptance to publication36 days
CiteScore4.900
Journal Citation Indicator-
Impact Factor-
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.